Australia's largest stock trading and investment forum Australia's #1 stock forum

92E

Click for more information

0.00%

50.0¢ 92 energy limited

Ann: 92E Intersects 41.8m of 0.5% eU3O8 at the GMZ Discovery, page-28

First 28 Last

Share
Profile

Follow
Johnyb888

1,461 Posts.

1006

13/07/22

20:00

Post #: 62522181
Share

Originally posted by James7821: ↑

It's already correcting. The company has no resource, just spending obligations. What it finds won't be mined for half a decade, and another half a decade before it's turned into energy. It will not bounce back on fundamentals, if it does, it will bounce back on broader market rise in the U space, or market overall.

U investors are so focused on underlying fundamentals they forget the general market macro. They are long dated stocks, probably the MOST long dated out of any sector in the market, including unprofitable tech. So it seems this rate rise thematic is the reason why U stocks have been hit so badly.

I still like 92E, but this macro and its impact on stocks like 92E is clear.

Expand

Nonsense. Uranium companies are for a good part valued on pounds in the ground.

Look at Nexgen. Still a decade or so from production, yet a multi billion dollar company.

92E's drill results are simply outstanding. And totally not priced in. But they will be in the next couple of years (possibly months).

Check back here in 2024!

92E Price at posting: 42.5¢ Sentiment: Buy Disclosure: Held
11 Upvote

4 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 4 more messages in this thread...

First 28 Last

Add 92E (ASX) to my watchlist